- Previous Close
0.0800 - Open
0.0800 - Bid 0.0780 x --
- Ask 0.0810 x --
- Day's Range
0.0800 - 0.0800 - 52 Week Range
0.0490 - 0.6500 - Volume
93,625 - Avg. Volume
1,013,568 - Market Cap (intraday)
46.653M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1300 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Enlitic, Inc. operates in the healthcare IT sector in the United States, Europe, and Japan. The company uses artificial intelligence (AI) to develop software products that manage medical imaging data in radiology, such as magnetic resonance imaging, computed tomography scans, X-ray, and ultrasound images, and licenses such products to healthcare providers and original equipment manufacturers. Its healthcare data solutions include ENDEX, a medical imaging solution that standardizes and structures data from medical images; and ENCOG, a solution designed to de-identify medical imaging data while retaining clinically relevant information. The company also offers Enlitic Curie, an extensible data management framework powered by AI that allows easy implementation and orchestration of Enlitic application modules. It provides solutions to radiologists, IT and PACS administrators, hospital executives, and researchers. The company was formerly known as You Partners, Inc. Enlitic, Inc. was incorporated in 2014 and is based in Fort Collins, Colorado.
www.enlitic.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: ENL.AX
View MorePerformance Overview: ENL.AX
Trailing total returns as of 3/19/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ENL.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ENL.AX
View MoreValuation Measures
Market Cap
46.65M
Enterprise Value
35.83M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
8.95
Price/Book (mrq)
2.68
Enterprise Value/Revenue
21.01
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-76.46%
Return on Equity (ttm)
-138.73%
Revenue (ttm)
1.2M
Net Income Avi to Common (ttm)
-15.24M
Diluted EPS (ttm)
-0.1300
Balance Sheet and Cash Flow
Total Cash (mrq)
7.16M
Total Debt/Equity (mrq)
2.83%
Levered Free Cash Flow (ttm)
-8.67M